Search results for “Chronic lymphoblastic leukemia” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 491 patents, we discovered top 130 key players by total patent application. Alexion Pharmaceuticals, Inc., Juno Therapeutics, Inc., Celgene Corp. are dominant in this area. They take 15.07% of the total patent filing.
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 36
Juno Therapeutics, Inc.
Washington, United States
Patent: 21
Celgene Corp.
New Jersey, United States
Patent: 17
Eli Lilly & Co.
Indiana, United States
Patent: 16
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 14
Signal Pharmaceuticals LLC
California, United States
Patent: 13
Bristol Myers Squibb Co.
New York, United States
Patent: 11
Genzyme Corp.
Massachusetts, United States
Patent: 11
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 11
Centre of Molecular Immunology
Cuba
Patent: 11
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 16 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 15
STARTUP
Immunophage
China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 152 patents applied in the last 5 years. We discover 62 most active companies in this area. The fast-growing Juno Therapeutics, Inc., Celgene Corp., Genmab A/S take 23.68% of patent filing during this period.
Juno Therapeutics, Inc.
Washington, United States
Patent: 17
Celgene Corp.
New Jersey, United States
Patent: 12
Genmab A/S
Hovedstaden, Denmark
Patent: 7
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 6
Universidade Federal de Minas Gerais
Minas Gerais, Brazil
Patent: 5
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 5
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 5
Jiangsu Provincial People's Hospital (the First Affiliated Hospital of Nanjing Medical University)
undefined undefined
Patent: 4
Fred Hutchinson Cancer Research Center
Washington, United States
Patent: 4
Bristol Myers Squibb Co.
New York, United States
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 152 patents in last 5 years, we discover 35 new entrants. Genmab A/S, Universidade Federal de Minas Gerais, Jiangsu Provincial People's Hospital (the First Affiliated Hospital of Nanjing Medical University) are the most active new entrants in this area.
Genmab A/S
Hovedstaden, Denmark
Patent: 7
Universidade Federal de Minas Gerais
Minas Gerais, Brazil
Patent: 5
Jiangsu Provincial People's Hospital (the First Affiliated Hospital of Nanjing Medical University)
undefined undefined
Patent: 4
Bio-Thera Solutions, Ltd.
Guangdong Sheng, China
Patent: 3
University of Washington
Washington, United States
Patent: 2
Institute of Basic Medical Sciences
Beijing Shi, China
Patent: 2
First Affiliated Hospital of Dalian Medical University
Liaoning Sheng, China
Patent: 2
Longtaishen Pharmaceutical Technology (Nanjing) Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Dalian Medical University
Liaoning Sheng, China
Patent: 2
EnhancedBio, Inc.
South Korea
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 163 patents, we discovered top 31 universities and scientific research institutions by total patent application. Université de Bretagne Occidentale, Thomas Jefferson University, University of Rochester are dominant in this area. They take 25.77% of the total patent filing.
Université de Bretagne Occidentale
France
Patent: 13
Thomas Jefferson University
Pennsylvania, United States
Patent: 12
University of Rochester
New York, United States
Patent: 8
Masaryk University
Czechia
Patent: 7
Texas A&M University
Texas, United States
Patent: 5
University of Lodz
Poland
Patent: 5
Universidade Federal de Minas Gerais
Minas Gerais, Brazil
Patent: 5
Centre Hospitalier Universitaire de Brest
France
Patent: 4
The Ohio State University
Ohio, United States
Patent: 3
Université de Paris 5 René Descartes
France
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: